Close Menu

PerkinElmer, Helix GenePrism:Actionable Insights

Apr 02, 2019

PerkinElmer and Helix have launched GenePrism:Actionable Insights, a genetic screening test that they said is the "most comprehensive clinical grade DNA sequencing and interpretation" test currently on the market. The test allows users to learn about their risk for underlying diseases. A user's DNA will be sequenced by Helix and the results will be interpreted by board-certified geneticists at PerkinElmer Genomics using ordered data interpretation network, that firm's proprietary high-throughput software platform. In comparison to other commercial firms that look at a limited number of letters in a gene sequence, GenePrism:Actionable Insights assesses each of 59 genes in its entirety, including BRCA1/2, the partners said. They also noted that PerkinElmer Genomics maintains one of the largest databases of known genetic variations from different ancestries globally providing customers with a more in-depth assessment. 

More Like This

Sep 20, 2019

Toyobo RNA Analysis Kit

Toyobo of Japan is releasing RNA Analysis Kit for full-length sequencing of total RNA from a single cell. The kit is based on a method called RamDA-seq that was developed by researchers at the Laboratory for Bioinformatics Research at the Riken Center for Biosystems Dynamics Research in Japan. The method enables RNA amplification with low bias and the comprehensive identification of RNA varieties and their amounts in a single cell. The kit will officially be launched on Sept. 30.

Sep 18, 2019

Yourgene Elucigene DPYD

UK-based Yourgene has launched the Elucigene DPYD assay, a CE-marked chemotoxicity diagnostic test that uses genotyping to identify cancer patients with dihydropyrimidine dehydrogenase (DPD) deficiency. The deficiency causes several and sometimes lethal side effects in patients treated with 5-fluorouracil (5-FU), which is metabolized by the DPD enzyme, encoded by the DPYD gene. Elucigene DPYD, which tests for six common genetic variations, conforms with Clinical Pharmacogenetics Consortium guidelines, which recommend testing for four clinically relevant mutations.

Sep 17, 2019

Biognosys Spectronaut 13.7

Biognosys of Switzerland has released a new version of its Spectronaut 13 mass spectrometry analysis software. The update, version 13.7, includes beta support for the parallel accumulation-serial fragmentation (PASEF) and diaPASEF methods, which are available on Bruker's timsTOF Pro instrument.

Sep 12, 2019

Euformatics OmnomicsQ Ion Torrent Suite Plugin

Euformatics has launched the OmnomicsQ Ion Torrent Suite plugin. The software can be fully integrated with Thermo Fisher Scientific Ion Torrent sequencers to enable users to access quality control metrics and graphics as part of their workflows without the need for manual external program integration. The plugin gives Ion Torrent Suite users quality information for every sample run as part of their standard run procedure, helping to eliminate errors and flagging any issues with data quality before it affects patients, Helsinki-based Euformatics noted. In addition, the plugin enables users to perform clinical test validation of their next-generation sequencing pipelines with the OmnomicsV validation and verification software.

Sep 09, 2019

Sphere Fluidics Cyto-Cellect Human IgGk Detection Kit

Sphere Fluidics has launched its Cyto-Cellect Human IgGk Detection Kit to measure antibody class and productivity for cell line development. The FRET-based assay detects the presence of human IgG from encapsulated cells in picodroplets with kappa light chain after secretion, characterizing and measuring antibody production. According to the firm, users can combine the kit with with the Cyto-Mine Single Cell Analysis System.  

Sep 09, 2019

Fluidigm Advanta RNA-Seq NGS Library Prep Kit

Fluidigm has launched its Advanta RNA-Seq NGS Library Prep Kit, which runs on the firm's Juno microfluidic system. According to the firm, the next-generation sequencing kit allows researchers to reduce their costs for full-length stranded libraries by up to 50 percent. Fluidigm noted that the automated workflow can also reduce the number of operator interventions and total hands-on time to about two hours. The kit allows researchers to simultaneously process up to 48 samples using a integrated microfluidic circuit (IFC). By integrating solid-phase sample enrichment with sequential enzymatic reaction on the IFC, the workflow automates multiple reaction steps to product up to 48 libraries for sequencing on Illumina systems. 

Sep 06, 2019

Fluidigm Maxpar Imaging Mass Cytometry Kits; CyTOF Software

Fluidigm this week launched three new imaging mass cytometry kits and new CyTOF software at the 2019 World Molecular Imaging Congress.

Fluidigm's Maxpar Human Immuno-Oncology Panel Kits are designed for immune-oncology research. Developed using pathologist-verified antibodies, the panels can be mixed and matched to profile tumor-infiltrating lymphocytes, immune cell activation states, and tissue architecture. By combining them as a single 18-marker panel, researchers can broadly profile activated tumor-infiltrating lymphocytes for single-cell analysis of tumor architecture from a single tissue scan, Fluidigm said.

Fluidigm's CyTOF software, meantime, is designed to be used with the Hyperion Imaging System for cellular biomarker identification. According to the firm, the software streamlines the selection and acquisition of multiple regions of interest (ROI) from each slide. Researchers can remotely annotate those ROIs using brightfield reference images to guide automated batch acquisition of highly multiplexed images at 1-micron resolution. During image acquisition, researchers can visualize multiplexed images in real time across all detection channels to ensure data quality, Fluidigm said.

Sep 05, 2019

Swift Biosciences RNA Library Kits

Swift Biosciences has launched its RNA Library Kits. With patented Adaptase technology, the kits allow direct conversion of first-strand complementary DNA, reverse transcribed from RNA, into libraries for Illumina sequencing.

The firm is offering two kits: the Swift RNA Library Kit, which supports a broad input range from as little as 10 nanograms of total RNA or 100 picograms of poly(A)-enriched messenger RNA or ribosomal RNA-depleted RNA, and the Swift Rapid RNA Library Kit, which is faster and lower-priced. Both kits are available in 24- or 96-reaction kits.

The products include an RNA fragmentation module, a reverse transcription module, library prep reagents, polymerase, and several indexing primer kit options for single, combinatorial, and unique dual indexing.

Sep 04, 2019

Xifin LIS 6

Xifin has introduced a new version of its laboratory information system, Xifin LIS 6. The latest iteration of the software-as-a-service platform includes several features resulting from recently formed partnerships. Notably, Xifin LIS 6 includes artificial intellegence-driven genomic data interpretation, thanks to a partnership with Fabric Genomics. The new release supports fast, scaleable analysis of next-generation sequencing to produce "physician-ready" clinical reports, the company said.  

Other upgrades in LIS 6 include support for digital pathology workflows via a collaboration with Proscia, integration of Glidian's automated prior authorization technology, and access to test utilization support from the Medical Database LDS laborator decsion system.

Aug 16, 2019

Integrated DNA Technologies oPools Oligo Pools

Integrated DNA Technologies has launched its oPools Oligo Pools, ready-to-use pools of high-quality DNA oligonucleotides. According to the Coralville, Iowa-based firm, the pools contain customized, single-stranded DNA sequences between 40 and 350 nucleotides in length. Because the pools are delivered in picomoles, researchers do not need to perform any pre-amplification or other pre-work before using the pool. IDT said that oPools' low error rate of less than 1 in 2,000 nucleotides, coupled with high per-oligo yields, allow researchers to immediately proceed into their downstream workflows including CRIPSR library construction, protein screening, and gene assembly.   

Aug 15, 2019

Loop Genomics LoopSeq Bacterial Genome Sequencing Kit and Services

Loop Genomics has launched a new sample preparation kit and service for de novo bacterial genome assembly using synthetic long reads on Illumina sequencers.

The LoopSeq Bacterial Genome Sequencing kit leverages the firm's chemistry and computational pipeline to create reads thousands of base pairs long, providing high-quality assemblies with fewer total contigs, higher N50 values, and fewer misassemblies.

San Jose, California-based Loop Genomics said the kit is plug-and-play and can easily replace existing sample preparation kits for bacterial genome sequencing experiments, using Loop's software for data analysis.

Aug 13, 2019

Dovetail Genomics Omni-C Assay

Dovetail Genomics has launched the Omni-C, a new assay based on the Hi-C method for chromosome conformation capture.

Scotts Valley, California-based Dovetail said it designed the assay for ease of use and improved reproducibility. The firm claims the assay offers better coverage compared to standard Hi-C approaches, by using an endonuclease, rather than restriction enzymes, to digest cross-linked chromatin.

Traditional restriction enzyme-based Hi-C approaches generate data only near the restriction enzyme sites, resulting in gaps of information. By using an endonuclease, Omni-C enables coverage of a significant portion of the genome that does not contain these restriction sites, estimated to be around 20 percent in human genomes. 

Applications for Omni-C include structural genetic variant detection and generating genome assemblies. 

Aug 09, 2019

Streck ARM-D Kits; RNA Complete BCT

Streck this week launched three new real-time PCR antibiotic resistance kits for research use only. The kits cover MCR, expanded OXA, and TEM/SHV/GES to detect variants of resistance genes considered by the US Centers for Disease Control.

Streck also introduced RNA Complete BCT, a direct-draw whole-blood collection tube containing a specially designed reagent which maintains the draw-time concentration of extracellular vesicles such as exosomes for up to 7 days at room temperature storage.

Aug 08, 2019

Novogene NovoPM 2.0 Cancer Panel

Chula Vista, California-based Novogene has launched its NovoPM 2.0 Cancer Panel, a next-generation sequencing panel that analyzes 484 solid tumor-related genes and introns in 43 genes. According to the firm, the test can detect four types of genomic abnormalities (single nucleotide variation, insertions/deletions, copy number variation, and fusions), and features bioinformatics software including three algorithms specific for guiding cancer immunotherapy decision making.

Aug 08, 2019

ChunLab TrueBac ID

Korean bioinformatics firm ChunLab has launched TrueBac ID, a cloud-based platform that combines proprietary algorithms and a manually curated reference database for bacterial identification targeting more than 12,000 species. The system can provide a full identification report within 30 minutes after a user uploads a genome assembly or raw shotgun sequencing data as a FASTQ file. The report provides fully resolved taxonomic classification, antimicrobial resistance genes, and virulence genes to facilitate correct diagnosis and appropriate therapy. In a recently published study, TrueBac ID was able to accurately identify 34 of 36 clinical isolates (94.4 percent) that were not identified using three commercially available MALDI-TOF MS systems. ChunLab said that it is providing the service for free to all users until the end of 2019 with certain restrictions. In 2020, the company plans to add functions such as strain typing to the platform.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.